Trump administration considers measures to limit DTC drug advertising: Bloomberg
The Trump administration is weighing measures that would make it more expensive for pharmaceutical companies to conduct direct-to-consumer (DTC) advertising, according to a report from Bloomberg.
The Trump administration is weighing measures that would make it more expensive for pharmaceutical companies to conduct direct-to-consumer (DTC) advertising, according to a report from Bloomberg.
